BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $6.68 billion. The enterprise value is $7.73 billion.

Market Cap	6.68B
Enterprise Value	7.73B

Important Dates

The next estimated earnings date is Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

BBIO has 190.19 million shares outstanding. The number of shares has increased by 14.30% in one year.

Current Share Class	190.19M
Shares Outstanding	190.19M
Shares Change (YoY)	+14.30%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	5.16%
Owned by Institutions (%)	67.99%
Float	138.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	29.44
Forward PS	30.17
PB Ratio	-4.58
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	34.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.67

Current Ratio	4.67
Quick Ratio	4.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.65

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-47.83%
Return on Invested Capital (ROIC)	-104.60%
Return on Capital Employed (ROCE)	-73.32%
Revenue Per Employee	$303,975
Profits Per Employee	-$733,921
Employee Count	730
Asset Turnover	0.30
Inventory Turnover	n/a

Taxes

In the past 12 months, BBIO has paid $1.15 million in taxes.

Income Tax	1.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.77% in the last 52 weeks. The beta is 1.07, so BBIO's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	+13.77%
50-Day Moving Average	34.25
200-Day Moving Average	28.33
Relative Strength Index (RSI)	53.76
Average Volume (20 Days)	2,827,400

Short Selling Information

The latest short interest is 20.18 million, so 10.61% of the outstanding shares have been sold short.

Short Interest	20.18M
Short Previous Month	18.78M
Short % of Shares Out	10.61%
Short % of Float	14.52%
Short Ratio (days to cover)	5.60

Income Statement

In the last 12 months, BBIO had revenue of $221.90 million and -$535.76 million in losses. Loss per share was -$2.88.

Revenue	221.90M
Gross Profit	218.02M
Operating Income	-560.87M
Pretax Income	-453.82M
Net Income	-535.76M
EBITDA	-554.79M
EBIT	-560.87M
Loss Per Share	-$2.88

Full Income Statement

Balance Sheet

The company has $681.10 million in cash and $1.73 billion in debt, giving a net cash position of -$1.05 billion or -$5.52 per share.

Cash & Cash Equivalents	681.10M
Total Debt	1.73B
Net Cash	-1.05B
Net Cash Per Share	-$5.52
Equity (Book Value)	-1.46B
Book Value Per Share	-7.72
Working Capital	566.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$520.73 million and capital expenditures -$933,000, giving a free cash flow of -$521.66 million.

Operating Cash Flow	-520.73M
Capital Expenditures	-933,000
Free Cash Flow	-521.66M
FCF Per Share	-$2.74

Full Cash Flow Statement

Margins

Gross margin is 98.25%, with operating and profit margins of -252.75% and -241.44%.

Gross Margin	98.25%
Operating Margin	-252.75%
Pretax Margin	-244.34%
Profit Margin	-241.44%
EBITDA Margin	-250.02%
EBIT Margin	-252.75%
FCF Margin	n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.30%
Shareholder Yield	n/a
Earnings Yield	-8.02%
FCF Yield	-7.81%

Dividend Details

Analyst Forecast

The average price target for BBIO is $52.90, which is 50.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$52.90
Price Target Difference	50.67%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	59.62%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BBIO has an Altman Z-Score of -4.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.43
Piotroski F-Score	5